Health
Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection – News-Medical.Net
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine…
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.
Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection.
Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed…
-
General13 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General16 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News15 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business12 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher